BPX-601
BP-012
Phase 1 mab terminated
Quick answer
BPX-601 for Metastatic Castration-resistant Prostate Cancer is a Phase 1 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated